Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The interaction of chloride, choline, noradrenaline and 5-hydroxytryptamine with a purified synaptic plasma membrane fraction.

Neuroscience letters·2009

Same author

Effects of post- and pre-synaptic snake venom neurotoxins on chloride and choline association with synaptic plasma membranes in vitro.

Neuroscience letters·2009

Same author

Pain management for sickle cell disease.

The Cochrane database of systematic reviews·2006

Same author

Is there such a thing as a life not worth living?

BMJ (Clinical research ed.)·2001

Same author

Force output and energy metabolism during neuromuscular electrical stimulation: a 31P-NMR study.

Scandinavian journal of rehabilitation medicine·1997

Same author

Octreotide and the secretory effects of advanced cancer.

Palliative medicine·1996

Search research articles

Related Experiment Video

Updated: Jul 23, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Cytokines and advanced cancer.

R J Dunlop¹, C W Campbell

¹St. Christopher's Hospice, Esher, Surrey, United Kingdom.

Journal of Pain and Symptom Management

|October 6, 2000

Summary

Cytokines, signaling proteins, are implicated in cancer progression and symptoms like pain and fatigue. New anti-cytokine therapies may offer better symptom control for advanced cancer patients.

Area of Science:

Oncology
Immunology
Cancer Biology

Background:

Cytokines play a crucial role in cancer development and metastasis.
Elevated cytokine levels are frequently observed in individuals with cancer.
Cytokines are linked to numerous symptoms in advanced cancer.

Purpose of the Study:

To review the role of cytokines in cancer progression.
To highlight the contribution of cytokines to cancer-related symptoms.
To explore the potential of anti-cytokine therapies for symptom management.

Main Methods:

Review of existing animal and human studies.
Analysis of the link between cytokines and cancer symptoms.
Examination of current research into anti-cytokine treatments.

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Experiment Videos

Last Updated: Jul 23, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Main Results:

Cytokines promote tumor growth and spread.
Cytokines contribute to asthenia, pain, cognitive dysfunction, anorexia, cachexia, fever, and metabolic issues in advanced cancer.
Development of anti-cytokine treatments is underway.

Conclusions:

Cytokines are key drivers of cancer progression and associated symptoms.
Targeting cytokines offers a promising avenue for managing difficult-to-control symptoms in advanced cancer.
Anti-cytokine therapies represent a potential new treatment modality.